Viewing Study NCT06315751


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
Study NCT ID: NCT06315751
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2023-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Sponsor: Noema Pharma AG
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-09-10
Start Date Type: ACTUAL
Primary Completion Date: 2026-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-04
Completion Date Type: ESTIMATED
First Submit Date: 2023-12-06
First Submit QC Date: None
Study First Post Date: 2024-03-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-30
Last Update Post Date: 2025-12-05
Last Update Post Date Type: ESTIMATED